FN2 Earnings Intelligence
IDEXX Laboratories, Inc. ratios (quarterly)
IDEXX Laboratories, Inc. (IDXX) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $164 | $164.6 | $208.2 | $200.5 | $196.9 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $998.4 | $1,109.5 | $1,105.2 | $1,140.8 | $1,216.6 | $1,191.4 | $1,174.4 |
| % Growth | - | - | - | - | - | 7.8% | - |
| Gross Profit | $623.4 | $694.7 | $683.4 | $722.7 | $779.1 | - | - |
| % Margin | 62.4% | 62.6% | 61.8% | 63.4% | 64.0% | - | - |
| EBITDA | $350.6 | - | - | $400.3 | - | - | - |
| % Margin | 35.1% | - | - | 35.1% | - | - | - |
| Net Income | $242.7 | $294 | $274.6 | $278.4 | $338.4 | - | - |
| % Margin | 24.3% | 26.5% | 24.8% | 24.4% | 27.8% | - | - |
| Diluted EPS | $2.96 | $3.63 | $3.40 | $3.47 | $4.27 | $3.72 | $3.39 |
| % Growth | - | - | - | - | - | 9.5% | - |
| Operating Cash Flow | $238 | - | - | $266.2 | - | - | - |
| CapEx | $30 | - | - | $32 | - | - | - |
| Free Cash Flow | $207.9 | - | - | $234.3 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $998.4 | $1,109.5 | $1,105.2 | $1,140.8 | $1,216.6 | $1,191.4 | $1,174.4 |
| Gross Profit | $623.4 | $694.7 | $683.4 | $722.7 | $779.1 | - | - |
| EBITDA | $350.6 | - | - | $400.3 | - | - | - |
| Net Income | $242.7 | $294 | $274.6 | $278.4 | $338.4 | - | - |
| Diluted EPS | $2.96 | $3.63 | $3.40 | $3.47 | $4.27 | $3.72 | $3.39 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $164 | $164.6 | $208.2 | $200.5 | $196.9 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $449.8 | $449.8 | $374.8 | $299.9 | $299.9 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $238 | - | - | $266.2 | - |
| Capital Expenditure | $30 | - | - | $32 | - |
| Free Cash Flow | $207.9 | - | - | $234.3 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 62.4% | 62.6% | 61.8% | 63.4% | 64.0% |
| EBITDA Margin | 35.1% | - | - | 35.1% | - |
| Net Margin | 24.3% | 26.5% | 24.8% | 24.4% | 27.8% |
| FCF Margin | 20.8% | - | - | 20.5% | - |
| Diluted EPS Growth | - | - | - | - | - |
Get the IDXX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.